Iberahim et al reported that syndecan-1 potentiated Wnt signaling and modulated the cancer stem cell phenotype via the regulation of LRP6 expression in triple-negative breast cancer cells [42]. The gene discussed is SDC1; the disease is triple-negative breast carcinoma.